Janet Kukreja, MD

Professional Titles

• Urologic Oncologist

Recognitions

• John Quale Travel Fellowship, Bladder Cancer Advocacy Network (2017)
• Outstanding Laparoendoscopic Resident Award, Society for Laparoendoscopic Surgeons (2017)
• Medical Staff Quality Improvement Award, University of Colorado Hospital (2021)

Research Interests

Publications

• Berrondo C, Feng C, Kukreja JB, Messing EM, Joseph JV. Antibiotic prophylaxis at the time of catheter removal after radical prostatectomy: A prospective randomized clinical trial. Urol Oncol. 2018 Dec 14. [Epub ahead of print] PubMed PMID: 30558984
• Joseph JV, Brasacchio R, Fung C, Reeder J, Bylund K, Sahasrabudhe D, Yeh SY, Ghazi A, Fultz P, Rubens D, Wu G, Singer E, Schwarz E, Mohile S, Mohler J, Theodorescu D, Lee YF, Okunieff P, McConkey D, Rashid H, Chang C, Fradet Y, Guru K, Kukreja J, Sufrin G, Lotan Y, Bailey H, Noyes K, Schwartz S, Rideout K, Bratslavsky G, Campbell SC, Derweesh I, Abrahamsson PA, Soloway M, Gomella L, Golijanin D, Svatek R, Frye T, Lerner S, Palapattu G, Wilding G, Droller M, Trump D. A Festschrift in Honor of Edward M. Messing, MD, FACS. Bladder Cancer. 2018 Oct 3;4(Suppl 1):S1-S43. PubMed PMID: 30443561
• Kukreja JB, Metcalfe MJ, Qiao W, Kamat AM, Dinney CPN, Navai N. Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort. Eur Urol Focus. 2018 Jul 19. [Epub ahead of print] PubMed PMID: 30033071
• Kukreja JB, Shi Q, Chang CM, Seif MA, Sterling BM, Chen TY, Creel KM, Kamat AM, Dinney CP, Navai N, Shah JB, Wang XS. Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy. Surg Innov. 2018 Jun;25(3):242-250. PubMed PMID: 29557251
• Kukreja JEB. Perioperative venous thromboembolism in urologic oncology procedures, risk factors, and prevention. Curr Opin Urol. 2018 May;28(3):227-232. PubMed PMID: 29465471
• Li R, Metcalfe M, Kukreja J, Navai N. Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review. Bladder Cancer. 2018 Jan 20;4(1):31-40. PubMed PMID: 29430505
• Kukreja JB, Thompson IM Jr, Chapin BF. Organizing a clinical trial for the new investigator. Urol Oncol. 2018 Feb 1. [Epub ahead of print] PubMed PMID: 29395953
• Li R, Baack Kukreja JE, Kamat AM. Secondary Tumors After Urinary Diversion. Urol Clin North Am. 2018 Feb;45(1):91-99. PubMed PMID: 29169454
• Kukreja JB, Porten S, Golla V, Ho PL, Noguera-Gonzalez G, Navai N, Kamat AM, Dinney CPN, Shah JB. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. Eur Urol Focus. 2018 Sep;4(5):720-724. PubMed PMID: 28753837
• Baack Kukreja J, Seif MA, Lozano M, Wang X, Hwang H, Kamat AM, Dinney CPN, Navai N. Preoperative immunonutrition in patients treated with radical cystecotmy, results from a phase 1, “Oral Immunonutrition to Enhance Recovery after Surgery” feasibility trial. AUA, Chicago, IL May 2019. (presented by Baack Kukreja)
• Baack Kukreja J, Navai N, Li J, Meng Q, Seif MA, Hwang H, Kamat AM, Westney OL, Dinney CPN. Testosterone levels and perioperative outcomes in patients treated with radical cystectomy, results from the “Oral Immunonutrition to Enhance Recovery after Surgery” trial. AUA, Chicago, IL May 2019. Podium presentation. (presented by Baack Kukreja)
• Baack Kukreja J, Seif MA, Kamat AM, Dinney CPN, Navai N. Surgical Quality of Radical Cystectomy. GU ASCO, San Francisco, CA February 2019. (presented by Baack Kukreja)
• Baack Kukreja J, Seif MA, Kamat AM, Dinney CPN, Navai N. Surgical Quality of Radical Cystectomy. IBCN, Rotterdam, Amsterdam Oct 2018. (presented by Baack Kukreja)
• Baack Kukreja J, Bathala TK, Reichard CA, Troncoso P, Delacroix S, Davies B, Smaldone M, Siddiqui MM, Tollefson M, Chapin BF. Impact of Preoperative Prostate Magnetic Resonance Imaging on the Surgical Management of High Risk Prostate Cancer. SCSAUA, Nashville, TN Sept 2018. (presented by Baack Kukreja)
• Baack Kukreja J, Jaber YM, Reichard CA, Achim MF, Davis JW, Chapin BF. Do Socioeconomic Factors Predict Clinical Trial Enrolment for Neoadjuvant Treatment in High Risk Prostate Cancer Trials Prior to Prostatectomy? A Propensity Matched Analysis. SCSAUA, Nasheville, TN Sept 2018. Podium Presentation. (presented by Baack Kukreja)
• Baack Kukreja J, Mery MW, Incalcaterra JR, Kamat AM, Dinney CPN, Navai N, Shah JB, Feeley TW. Drivers of Cost for an Episode of Care in Radical Cystectomy. AUA, San Francisco, CA May 2018. (presented by Baack Kukreja)
• Truong M, Baack Kukreja J, Nuffer Z, Barashi NS, Wang B, Park JH, Lam K, Feng C, Frye TP, Rais-Bahrami S, Nix JW, Thomas JV, Chapin BF, Davis JW, Eggener SE, Joseph JV, Hollenberg G, Weinberg E, Messing EM. Multi-institutional Machine Learning Tool for Predicting High Risk Lesions on 3 Tesla Multiparametric Prostate MRI. AUA, San Francisco, CA May 2018. (presented by Truong)
• Reichard CA, Bathala T, Gregg J, Kukreja J, Achim M, Davis JW, Chapin BF. CT Scan Has High Rate of Incidental Findings and Low Clinical Utility in A Cohort of High Risk Prostate Cancer Patients Staged With 99mtc Bone Scan and Pelvic MR. Society of Urologic Oncology Meeting, Washington DC November 2017. (presented by Reichard)
• Truong M, Baack Kukreja J, Rais-Bahrami S, Barashi N, Wang B, Nuffer Z, Park JH, Lam K, Frye T, Nix J, Thomas J, Feng C, Chapin BF, Davis JW, Hollenberg G, Oto A, Eggener S, Joseph J, Weinberg E, Messing E. Multi-Institutional Development of A Pretest Probability Calculator for High Risk Lesions on Multiparametric Prostate MRI. Society of Urologic Oncology Meeting, Washington DC November 2017. (presented by Truong)
• Baack Kukreja J, Metcalfe MJ, Qiao W, Nguyen JV, Sundi D, Kamat AM, Dinney CPN, Navai N. Cost-Effectiveness of Robot-Assisted Radical Cystectomy Using a Propensity Matched Cohort. International Bladder Cancer Network Annual Meeting, Lisbon, Portugal November 2017. (presented by Navai)
• Berrondo C, Changyong F, Kukreja J, Messing EM, Joseph JV. Antibiotic prophylaxis prior to urinary catheter removal after radical prostatectomy does not prevent urinary tract infections: A randomized controlled clinical trial. AUA Annual Meeting, Boston, MA May 2017. (presented by Berrondo)
• Reichard CA, Baack Kukreja J, Gregg JR, Bathala TK, Achim MF, Wang X, Davis JW, Nguyen QN, Chapin BF. Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design. Eur Urol Focus. May 2019;S2405-4569(19)30132-4. Epub ahead of print. PMID: 31076357
• Li R, Kukreja JEB, Seif MA, Petros FG, Campbell MT, Nguyen JV, Conzalez GMN, Kamat AM, Pisters LL, Dinney CP, Navai N. The role of metastatic burden in cytoreductive/consolidative radical cystectomy. World J Urol Mar 2019. PMID: 30864005.
• Kukreja JB, Thompson IM Jr, Chapin BF. Organizing a clinical trial for the new investigator. Urol Oncol. 2019 May;37(5):336-339. PMID 2939593.
• Baack Kukreja J, Ismaeel N, Navai N, Kamat AM, Dinney CPN, Shah JB. Outcomes and survival in non-Bilharzial pure squamous cell bladder cancer in patients undergoing curative radical cystectomy. GU-ASCO Annual Meeting, Orlando, FL Feb 2017. (presented by Baack Kukreja)
• Baack Kukreja J, Podolnick J, Wang X, Chen HS, Navai N, Kamat AM, Dinney CPN, Shah JB. Pre-surgery neutrophil-to-lymphocyte ratio is significantly associated with survival outcomes in patients undergoing radical cystectomy, regardless of neoadjuvant chemotherapy status. GU-ASCO Annual Meeting, Orlando, FL Feb 2017. (presented by Baack Kukreja)
• Baack Kukreja JE, Lloyd G.L. Robotically Assisted Radical Cystectomy. In: Best S., Nakada S. (eds) Minimally Invasive Urology. Springer, New York, NY, 2019.
• Pessoa R, Navai N, Kukreja JB. EDITORIAL COMMENT. Urology. 2020 Jan;135:64-65. PubMed PMID: 31895682
• Truong M, Baack Kukreja JE, Rais-Bahrami S, Barashi NS, Wang B, Nuffer Z, Park JH, Lam K, Frye TP, Nix JW, Thomas JV, Feng C, Chapin BF, Davis JW, Hollenberg G, Oto A, Eggener SE, Joseph JV, Weinberg E, Messing EM. Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging. Eur Urol Oncol. 2019 May;2(3):257-264. PubMed PMID: 31200839
• Baack Kukreja J. Venous Thromboembolism Prophylaxis in Urologic Surgery. AUA Update Series.
• Pessoa RR, Kukreja J. Editorial Comment. J Urol. 2019 Dec;202(6):1253. PubMed PMID: 31469612
• Li R, Kukreja JEB, Seif MA, Petros FG, Campbell MT, Nguyen JV, González GMN, Kamat AM, Pisters LL, Dinney CP, Navai N. The role of metastatic burden in cytoreductive/consolidative radical cystectomy. World J Urol. 2019 Dec;37(12):2691-2698. PubMed PMID: 30864005
• Baack Kukreja J, Kamat AM. Strategies to minimize readmission rates following major urologic surgery. Ther Adv Urol. 2017 Oct;9(5):111-119. PubMed PMID: 28588648
• Truong M, Liang L, Kukreja J, O'Brien J, Jean-Gilles J, Messing E. Cautery artifact understages urothelial cancer at initial transurethral resection of large bladder tumours. Can Urol Assoc J. 2017 May;11(5):E203-E206. PubMed PMID: 28503235
• Baack Kukreja JE, Kiernan M, Schempp B, Siebert A, Hontar A, Nelson B, Dolan J, Noyes K, Dozier A, Ghazi A, Rashid HH, Wu G, Messing EM. Quality Improvement in Cystectomy Care with Enhanced Recovery (QUICCER) study. BJU Int. 2017 Jan;119(1):38-49. PubMed PMID: 27128851
• Broughton BL, Baron B, Kiernan M, Baack-Kukreja J, LaFaro VE, Larmon R, Rust K, Schempp BA, Yovanovich J. Cystectomy-Enhanced Recovery Program: Nursing Implications. Urol Nurs. 2017 Jan-Feb;37(1):9-14. PubMed PMID: 29240359
• Kukreja JB, Shah JB. Advances in surgical management of muscle invasive bladder cancer. Indian J Urol. 2017 Apr-Jun;33(2):106-110. PubMed PMID: 28469297
• Lee EK, Baack J, Duchene DA. Survey of practicing urologists: robotic versus open radical prostatectomy. Can J Urol. 2010 Apr;17(2):5094-8. PubMed PMID: 20398448
• Lee EK, Baack J, Penn H, Bromfield CT, Duchene DA, Thrasher JB, Holzbeierlein JM. Active surveillance for prostate cancer in a veteran population. Can J Urol. 2010 Dec;17(6):5429-35. PubMed PMID: 21172105
• Baack Kukreja JE, Scosyrev E, Brasacchio RA, Toy EP, Messing EM, Wu G. Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer. BJU Int. 2014 Dec;114(6):844-51. PubMed PMID: 26010047
• Kukreja JB, Messing EM. Editorial Comment. Urology. 2015 Nov;86(5):972-3. PubMed PMID: 26414727
• Kukreja JE, Levey HR, Scosyrev E, Kiernan M, Berrondo C, McNamee C, Wu G, Joseph JV, Ghazi A, Rashid H, Dozier A, Messing EM. Effectiveness and safety of extended-duration prophylaxis for venous thromboembolism in major urologic oncology surgery. Urol Oncol. 2015 Sep;33(9):387.e7-16. PubMed PMID: 25637953
• Li R, Petros FG, Kukreja JB, Williams SB, Davis JW. Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy. Investig Clin Urol. 2016 Dec;57(Suppl 2):S155-S164. PubMed PMID: 27995219
• Noyes K, Baack-Kukreja J, Messing EM, Schoeniger L, Galka E, Pan W, Xueya C, Fleming FJ, Monson JR, Mohile SG, Francone T. Surgical readmissions: results of integrating pre-, peri- and postsurgical care. Nurs Open. 2016 Jul;3(3):168-178. PubMed PMID: 27708827
• Baack Kukreja JE, Messing EM, Shah JB. Are we doing "better"? The discrepancy between perception and practice of enhanced recovery after cystectomy principles among urologic oncologists. Urol Oncol. 2016 Mar;34(3):120.e17-21. PubMed PMID: 26585947
• Danna BJ, Wood EL, Baack Kukreja JE, Shah JB. The Future of Enhanced Recovery for Radical Cystectomy: Current Evidence, Barriers to Adoption, and the Next Steps. Urology. 2016 Oct;96:62-68. PubMed PMID: 27164287
• Kukreja JB, Seif MA, Mery MW, Incalcaterra JR, Kamat AM, Dinney CP, Shah JB, Feeley TW, Navai N. Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost drivers. Urol Oncol. 2020 Dec 8. [Epub ahead of print] PubMed PMID: 33308972
• Kukreja JB, Metcalfe MJ, Qiao W, Kamat AM, Dinney CPN, Navai N. Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort. Eur Urol Focus. 2020 Jan 15;6(1):88-94. PubMed PMID: 30033071
• Kessler ER, Kukreja JB, Geiger CL, Fischer SM. Treating Elderly Patients With Muscle-Invasive Bladder Cancer. J Natl Compr Canc Netw. 2020 Jun;18(6):783-790. PubMed PMID: 32502977
• Reichard CA, Kukreja J, Gregg JR, Bathala TK, Achim MF, Wang X, Davis JW, Nguyen QN, Chapin BF. Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design. Eur Urol Focus. 2021 Jan;7(1):71-77. PubMed PMID: 31076357
• Baack Kukreja J, Bathala TK, Reichard CA, Troncoso P, Delacroix S, Davies B, Eggener S, Smaldone M, Minhaj Siddiqui M, Tollefson M, Chapin BF. Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):172-178. PubMed PMID: 31501508
• Narayan VM, Seif MA, Lim AH, Li R, Matulay JT, Kukreja JB, Qiao W, Hwang H, Shah JB, Pisters L, Kamat AM, Dinney C, Navai N. Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes. Urol Oncol. 2020 Apr;38(4):247-254. PubMed PMID: 31953001
• Pessoa R, Navai N, Kukreja JB. EDITORIAL COMMENT. Urology. 2020 Jan;135:64-65. PubMed PMID: 31895682
• Narayan VM, Seif MA, Lim AH, Li R, Matulay JT, Kukreja JB, Qiao W, Hwang H, Shah JB, Pisters L, Kamat AM, Dinney C, Navai N. Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes. Urol Oncol. 2020 Apr;38(4):247-254. PubMed PMID: 31953001
• Kukreja JB, Seif MA, Mery MW, Incalcaterra JR, Kamat AM, Dinney CP, Shah JB, Feeley TW, Navai N. Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost drivers. Urol Oncol. 2021 Apr;39(4):237.e1-237.e5. PubMed PMID: 33308972
• Pessoa R, Navai N, Kukreja JB. EDITORIAL COMMENT. Urology. 2020 Jan;135:64-65. PubMed PMID: 31895682
• Rodrigues Pessoa R, Mueller AC, Boxley P, Flaig TW, Piper C, Konety B, Yu JB, Gershman B, Kukreja J, Kim SP. Systematic review and meta-analysis of radiation therapy for high-risk non-muscle invasive bladder cancer. Urol Oncol. 2021 Nov;39(11):786.e1-786.e8. PubMed PMID: 33846085
• Rodrigues Pessoa R, Morrison JC, Konety B, Gershman B, Maroni P, Kukreja JB, Cost N, Flaig T, Kessler E, Sharma P, Kim SP. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy. Urol Oncol. 2021 Dec;39(12):832.e9-832.e15. PubMed PMID: 33820697
• Baack Kukreja J, Bathala TK, Reichard CA, Troncoso P, Delacroix S, Davies B, Eggener S, Smaldone M, Minhaj Siddiqui M, Tollefson M, Chapin BF. Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):172-178. PubMed PMID: 31501508
• Pessoa RR, Maroni P, Kukreja J, Kim SP. Comparative effectiveness of robotic and open radical prostatectomy. Transl Androl Urol. 2021 May;10(5):2158-2170. PubMed PMID: 34159098
• Kukreja JB, Schroeck FR, Lotan Y, Gore JL, Ullman R, Lipman RR, Murray MBB, Chisolm S, Smith AB. Discomfort and relieving factors among patients with bladder cancer undergoing office-based cystoscopy. Urol Oncol. 2021 Jun 20. [Epub ahead of print] PubMed PMID: 34162499
• Kukreja JB, Metcalfe MJ, Qiao W, Kamat AM, Dinney CPN, Navai N. Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort. Eur Urol Focus. 2020 Jan 15;6(1):88-94. PubMed PMID: 30033071
• AUA Core Curriculum on Urethral Cancer
• Rodriguez-Homs M, Baack Kukreja J. Biomarkers cancer biomarkers, past and future directions. Jan 2021. BJUI Compass. https://doi.org/10.1002/bco2.61.
• Pessoa-Rodriguez R, Boxley P, Kukreja J. Comparative effectiveness of Robotic and Open Radical Cystectomy. American Medical J. 2020. http://dx.doi.org/10.21037/amj-20-81
• Westerman ME, Bree KK, Msaouel P, Kukreja JB, Mantaring C, Rukundo I, Gonzalez MG, Gregg JR, Casteel KN, Matin SF. Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study. J Urol. 2022 Oct;208(4):886-895. PubMed PMID: 36082549
• Urkmez A, Pessoa-Rodriguez R, Kukreja N, Kukreja JEB. Enhanced Recovery after Surgery and Urology applications in 2020. Accepted to BJUI Compass. Open access 2020. DOI: 10.1002/bco2.9
• Kukreja JB, Schroeck FR, Lotan Y, Gore JL, Ullman R, Lipman RR, Murray MBB, Chisolm S, Smith AB. Discomfort and relieving factors among patients with bladder cancer undergoing office-based cystoscopy. Urol Oncol. 2022 Jan;40(1):9.e19-9.e27. PubMed PMID: 34162499
• Pessoa RR, Maroni P, Kukreja J, Kim SP. Comparative effectiveness of robotic and open radical prostatectomy. Transl Androl Urol. 2021 May;10(5):2158-2170. PubMed PMID: 34159098
• Rodrigues Pessoa R, Mueller AC, Boxley P, Flaig TW, Piper C, Konety B, Yu JB, Gershman B, Kukreja J, Kim SP. Systematic review and meta-analysis of radiation therapy for high-risk non-muscle invasive bladder cancer. Urol Oncol. 2021 Nov;39(11):786.e1-786.e8. PubMed PMID: 33846085
• Rodrigues Pessoa R, Morrison JC, Konety B, Gershman B, Maroni P, Kukreja JB, Cost N, Flaig T, Kessler E, Sharma P, Kim SP. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy. Urol Oncol. 2021 Dec;39(12):832.e9-832.e15. PubMed PMID: 33820697
• Kukreja JB, Li R, Narayan VM, Lim A, Seif M, Wang X, Kamat A, Dinney C, Navai N. Oncologic Equipoise Between Robotic and Open Radical Cystectomy. J Endourol. 2021 Aug;35(8):1168-1176. PubMed PMID: 33619985
• Rodriguez-Homs M, Baack Kukreja J. Bladder cancer biomarkers: Past and future directions. BJUI Compass. 2021 Jan;2(1):7-8. PubMed PMID: 35474658
• Kukreja JB, Seif MA, Mery MW, Incalcaterra JR, Kamat AM, Dinney CP, Shah JB, Feeley TW, Navai N. Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost drivers. Urol Oncol. 2021 Apr;39(4):237.e1-237.e5. PubMed PMID: 33308972
• Reichard CA, Kukreja J, Gregg JR, Bathala TK, Achim MF, Wang X, Davis JW, Nguyen QN, Chapin BF. Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design. Eur Urol Focus. 2021 Jan;7(1):71-77. PubMed PMID: 31076357
• Wiesen B, Atwell M, Leavitt C, Clark N, Kessler E, Lam E, Flaig T, Kukreja J, Kim S, Maroni P, Cost NG. Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO Oncol Pract. 2023 Dec 21;:OP2300580. [Epub ahead of print] PubMed PMID: 38127812
• Kukreja JB. Non-muscle-invasive Bladder Cancer: Side-by-Side Guideline Comparison. Eur Urol Focus. 2023 Nov;9(6):954-956. PubMed PMID: 37308343
• Welliver C, MacLachlan LS, Riggs S, Kukreja JB, Miles-Thomas J. A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence. Urol Pract. 2024 Nov;11(6):950-955. PubMed PMID: 39196671
• Wiesen B, Atwell M, Leavitt C, Clark N, Kessler E, Lam E, Flaig T, Kukreja J, Kim S, Maroni P, Cost NG. Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO Oncol Pract. 2024 Mar;20(3):361-369. PubMed PMID: 38127812
• Kukreja JB. Non-muscle-invasive Bladder Cancer: Side-by-Side Guideline Comparison. Eur Urol Focus. 2023 Nov;9(6):954-956. PubMed PMID: 37308343

Professional Memberships

• American College of Surgeons, Member
• International Bladder Cancer Network, Member
• American Urologic Association, Member
• Society of Urologic Oncology, Member
• Southwestern Oncology Group (SWOG), Investigator
• Rocky Mountain Urologic Society, Member
• Society of Women in Urology, Member
• Institute for healthcare, quality, safety and efficiency, Faculty
• South Centeral Section of the AUA, Member

Practice Locations

• University of Colorado Hospital
• Denver Health Medical Center
• Veterans Affairs Medical Center
• UCHealth Highlands Ranch Hospital

• University of Colorado Cancer Center

Specialty Information

• Urology, Board Certification (2020, 2020)
• Urologic Oncology, Certificate (2018)

• Cancers - Bladder Cancer
• Cancers
• Cancers - Cancer Surgery
• Cancers - Chemotherapy
• Cancers - Kidney Cancer
• Cancers - Prostate Cancer
• Cancers - Testicular Cancer
• Cancers - Urologic Cancer
• Surgery
• Surgery - Robotic Surgery
• Surgery - Urologic Surgery
• Failed Prior Surgery
• Kidneys and Urinary System
• Kidneys and Urinary System - Bladder Disease